A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects

Trial Identifier: D5084C00014
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05768360
Start Date: April 2023
Primary Completion Date: July 2023
Study Completion Date: July 2023
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
DE Berlin, DE, 14050